You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Amgen Inc. (AMGN $298.00)
- $298.00 P/E (TTM): 24.01X Cap: $160.06B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $578.88)
- $578.88 P/E (TTM): 14.41X Cap: $61.09B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $410.22)
- $410.22 P/E (TTM): 29.21X Cap: $104.58B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $154.75)
- $154.75 P/E (TTM): 18.89X Cap: $6.40B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,350.47)
- $1,350.47 P/E (TTM): 33.04X Cap: $26.86B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $6.29)
- $6.29 Cap: $492M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $7.68)
- $7.68 Cap: $18M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use